The price of TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares last traded on Wall Street rose 19.74% to $0.82.
Based on available information, 1 analysts follow TC Biopharm (Holdings) Plc (NASDAQ:TCBP). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $5.61 and a low of $5.61, we find $5.61. Given the previous closing price of $0.68, this indicates a potential upside of 725.0 percent. TCBP stock price is now 33.62% away from the 50-day moving average and -76.88% away from the 200-day moving average. The market capitalization of the company currently stands at $1.79M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Among analysts, 0 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $5.61 as their price target over the next twelve months.
In other news, Randall Diana Elizabeth, 10% Owner bought 70,000 shares of the company’s stock on Nov 30. The stock was bought for $350,000 at an average price of $5.00. Upon completion of the transaction, the 10% Owner now directly owns 70,000 shares in the company, valued at $57400.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 30, 10% Owner Randall Kenneth Edward bought 70,000 shares of the business’s stock. A total of $350,000 was incurred on buying the stock at an average price of $5.00. This leaves the insider owning 382,963 shares of the company worth $0.31 million. A total of 11.74% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TCBP stock. A new stake in TC Biopharm (Holdings) Plc shares was purchased by VIRTU FINANCIAL LLC during the first quarter worth $10,000. WELLS FARGO & COMPANY/MN invested $6,000 in shares of TCBP during the first quarter. In the first quarter, STEWARD FINANCIAL GROUP LLC acquired a new stake in TC Biopharm (Holdings) Plc valued at approximately $2,000.
A candlestick chart of TC Biopharm (Holdings) Plc (NASDAQ: TCBP) showed a price of $0.8586 on Thursday morning. During the past 12 months, TC Biopharm (Holdings) Plc has had a low of $0.42 and a high of $22.00. The fifty day moving average price for TCBP is $0.6139 and a two-hundred day moving average price translates $3.4957 for the stock.
The latest earnings results from TC Biopharm (Holdings) Plc (NASDAQ: TCBP) was released for Dec, 2022. The net profit margin was -36.10% and return on equity was 19.70% for TCBP.
